{"DataElement":{"publicId":"2782552","version":"2","preferredName":"Hematopoietic Cell Graft Infusion Procedure Other Adverse Event Specify","preferredDefinition":"The free-text field to describe other hematopoietic cell graft (product) infusion adverse event(s) or incident(s).","longName":"HC_INFU_OTH_AE_SPE","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2782550","version":"2","preferredName":"Hematopoietic Cell Graft Infusion Procedure Other Adverse Event","preferredDefinition":"Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc._Healthy skin, bone, or other tissue taken from one part of the body and used to replace diseased or injured tissue removed from another part of the body._A method of putting fluids, including drugs, into the bloodstream. Also called intravenous infusion._Different than the one(s) previously specified or mentioned. (NCI)._Any unfavorable or unintended symptom, sign, or disease including an abnormal laboratory finding) temporally associated with the use of a medical treatment or procedure that may or may not be considered related to the medical treatment or procedure.  Such events can be intervention related, dose related, route related, patient related, or caused by an interaction with another drug(s) or procedure(s).","longName":"HC_INFU_OTH_AE","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2779420","version":"1","preferredName":"Hematopoietic Stem Cell Graft Infusion Procedure","preferredDefinition":"Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.):Healthy skin, bone, or other tissue taken from one part of the body and used to replace diseased or injured tissue removed from another part of the body.:A method of putting fluids, including drugs, into the bloodstream. Also called intravenous infusion.","longName":"C12551:C12981:C15388","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hematopoietic Stem Cell","conceptCode":"C12551","definition":"Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Graft","conceptCode":"C12981","definition":"Tissue or organ transplanted from a donor to a recipient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Infusion Procedure","conceptCode":"C15388","definition":"Any form of treatment that is introduced into the body via a blood vessel, a muscle, or the spinal cord.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"55EF6012-D12C-09AE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-02","endDate":null,"createdBy":"ZHANGW","dateCreated":"2008-09-02","modifiedBy":"ONEDATA","dateModified":"2008-09-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2782548","version":"1","preferredName":"Other Adverse Event","preferredDefinition":"Not otherwise specified.:Any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, syndrome, or disease, temporally associated with the use of a medical product or procedure, regardless of whether or not it is considered related to the product or procedure (attribution of unrelated, unlikely, possible, probable, or definite). The concept refers to events that could be medical product related, dose related, route related, patient related, caused by an interaction with another therapy or procedure, or caused by opioid initiation or dose escalation. The term also is referred to as an adverse experience. The old term Side Effect is retired and should not be used.","longName":"C17649:C41331","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Adverse Event","conceptCode":"C41331","definition":"Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"568B168C-0BCE-5D05-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-10","endDate":null,"createdBy":"ZHANGW","dateCreated":"2008-09-10","modifiedBy":"ONEDATA","dateModified":"2008-09-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E49ED9EB-98B6-72C9-E040-BB89AD43168C","latestVersionIndicator":"Yes","beginDate":"2008-09-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-08-23","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2018370","version":"1","preferredName":"Adverse Event Specify","preferredDefinition":"the free text field to specify an adverse event.","longName":"AE_SPEC","context":"CTEP","contextVersion":"2.31","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184338","version":"1","preferredName":"Specify","preferredDefinition":"Specify; be specific about something; define clearly.","longName":"Specify","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-2084-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B30723CB-0BFA-05D8-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-10-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-30","modifiedBy":"CAMPBELB","dateModified":"2008-03-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964920","version":"1","longName":"2006r1: HSCT Infusion","context":"NHLBI"}]},{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"inf_prod_infuse_ae_oth_expect_spec","type":"NMDP_FN","context":"NHLBI"},{"name":"AdverseEvent:value ","type":"HCT_BRIDG","context":"NHLBI"},{"name":"Hematopoietic Stem Cell Graft Infusion Procedure Other Adverse Event Specify","type":"System-Generated","context":"NHLBI"},{"name":"inf_prod_infuse_ae_oth_unexpect_spec","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"Specify the other hematopoiet","type":"Preferred Question Text","description":"Specify the other hematopoietic cell infusion adverse event type:","url":null,"context":"NHLBI"},{"name":"Specify","type":"Alternate Question Text","description":"Specify","url":null,"context":"NHLBI"},{"name":"BRIDG mapping path for CDE:2782552","type":"BRIDG Mapping Path","description":"AdverseEvent.value(ANY=>CD).originalText WHERE AdverseEvent.occurenceDateRange IS BETWEEN PerformedProcedure.dateRange(IVL<TS.DATETIE>).low AND (PerformedProcedure.dateRange(IVL<TS.DATETIE>).low + 48 HOURS) AND PerformedProcedure > DefinedProcedure.nameCode = \"Administer Hematopoietic Stem Cell Product{transplantation}\" AND AdverseEvent.value(ANY=>CD).nullFlavor = \"OTH\"","url":null,"context":"NHLBI"},{"name":"Specify other expected AE:","type":"Alternate Question Text","description":"Specify other expected AE:","url":null,"context":"NHLBI"},{"name":"Specify other adverse event","type":"Application Standard Question Text","description":"Specify other adverse event","url":null,"context":"NHLBI"},{"name":"Specify other unexpected AE:","type":"Alternate Question Text","description":"Specify other unexpected AE:","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E49ED9EB-98E6-72C9-E040-BB89AD43168C","latestVersionIndicator":"Yes","beginDate":"2008-09-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-08-23","modifiedBy":"ALEYR","dateModified":"2019-04-07","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}